Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study-Reference-Cited by-同舟云学术

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Published:2001-08 Issue:9281 Volume:358 Page:527-533
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mehta Shamir R,Yusuf Salim,Peters Ron JG,Bertrand Michel E,Lewis Basil S,Natarajan Madhu K,Malmberg Klas,Rupprecht Hans-Jürgen,Zhao Feng,Chrolavicius Susan,Copland Ingrid,Fox Keith AA

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

2. Antiplatelet therapy in patients undergoing percutaneous coronary intervention;Popma;Chest,2001

3. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty;Schwartz;N Engl J Med,1988

4. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty;Barnathan;Circulation,1987

5. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease;Kong;Circulation,1998

Cited by 2774 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Antimicrobial Potential of the Hop (Humulus lupulus L.) Extract against Staphylococcus aureus and Oral Streptococci;Pharmaceuticals;2024-01-27

2. Aspirin-free antiplatelet strategies after percutaneous coronary interventions;European Heart Journal;2024-01-18

3. Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines;European Heart Journal: Acute Cardiovascular Care;2024-01-03

4. Toward Optimizing Antiplatelet Therapy for Patients at High Bleeding Risk;The American Journal of Cardiology;2024-01

5. Prasugrel Only May Be Enough After Percutaneous Coronary Intervention for Chronic Coronary Syndrome Patients;JACC: Asia;2024-01